Spasticity patterns assessment and recognition for therapeutic approaches (SPARTA) in multiple sclerosis: a multicenter epidemiological study
- 12 December 2024
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 272 (1) , 1-11
Abstract
Background Spasticity and muscle weakness are the most disabling symptoms in people with Multiple Sclerosis (pwMS), frequently affecting lower limbs and causing motor impairments, fatigue and increased risk of falls. Previous epidemiological studies on pwMS reported prevalence of spasticity and other symptoms but scarce information is available about combined patterns of muscle weakness and spasticity, symmetry and regional localization. Objectives To describe the prevalent combined patterns of muscle weakness and spasticity in pwMS in order to focus attention on their functional balance before spasticity treatment. Methods pwMS with lower limb spasticity, 3.5 ≤ Expanded-Disability-Status Scale (EDSS) ≤ 6.5 were recruited. Data regarding muscle weakness and spasticity, symmetry and involvement of other functional systems were collected. Prevalence analysis was performed. Results Three-hundred pwMS were included. Muscle weakness and spasticity occurred mostly asymmetrically with a prevalence of paraparesis. Incidence of both symptoms increase with higher EDSS, particularly of muscle weakness. Twelve prevalent combined patterns were identified, with highest incidence of combinations characterized by “distal-intermediate spasticity and diffuse weakness” (29.3%), “diffuse spasticity and weakness” (13.7%), “distal spasticity and diffuse weakness” (11.7%). Conclusions This study highlighted the most prevalent combined patterns of weakness and spasticity, useful in clinical practice for pwMS’ assessment by supporting optimal planning of specific pharmacologic and rehabilitative treatments.Keywords
This publication has 35 references indexed in Scilit:
- Short and long term effects of Nabiximols on balance and walking assessed by 3D-gait analysis in people with Multiple Sclerosis and spasticity.Multiple Sclerosis and Related Disorders, 2021
- Persons with Multiple Sclerosis Exhibit Strength Asymmetries in both Upper and Lower ExtremitiesPhysiotherapy, 2021
- Spasticity, spastic dystonia, and static stretch reflex in hypertonic muscles of patients with multiple sclerosisClinical Neurophysiology Practice, 2021
- Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysisMultiple Sclerosis and Related Disorders, 2020
- Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network studyNeurological Sciences, 2020
- Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task forceJournal of Neurology, 2016
- Spasticity in multiple sclerosis: Associations with impairments and overall quality of lifeMultiple Sclerosis and Related Disorders, 2016
- Effect of spasticity on kinematics of gait and muscular activation in people with Multiple SclerosisJournal of the Neurological Sciences, 2015
- Novel characterization of gait impairments in people with multiple sclerosis by means of the gait profile scoreJournal of the Neurological Sciences, 2014
- Plantarflexor Weakness Negatively Impacts Walking in Persons With Multiple Sclerosis More Than Plantarflexor SpasticityArchives of Physical Medicine and Rehabilitation, 2014